Thomas Decker Selected Research

Thomas Decker Research Topics

Disease

36	Neoplasms (Cancer) 01/2022 - 02/2002
32	Breast Neoplasms (Breast Cancer) 02/2022 - 02/2005
21	Infections 10/2021 - 12/2002
17	Colorectal Neoplasms (Colorectal Cancer) 07/2022 - 03/2011
13	Inflammation (Inflammations) 10/2021 - 05/2004
10	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 06/2022 - 02/2002
6	Disease Progression 01/2022 - 09/2007
6	Colitis 11/2015 - 11/2012
6	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2015 - 07/2003
4	B-Cell Lymphoma (Lymphoma, B Cell) 01/2022 - 05/2012
3	Bites and Stings (Sting) 01/2020 - 08/2014
3	Lymphoma (Lymphomas) 01/2018 - 07/2003
3	Sepsis (Septicemia) 12/2016 - 03/2003
3	Necrosis 08/2009 - 02/2008
3	Genetic Translocation (Chromosomal Translocation) 10/2006 - 07/2003
2	Microsatellite Instability 07/2022 - 01/2020
2	Renal Cell Carcinoma (Grawitz Tumor) 12/2021 - 01/2020
2	Neoplasm Metastasis (Metastasis) 12/2021 - 01/2021
2	Noninfiltrating Intraductal Carcinoma (DCIS) 06/2018 - 01/2018
2	Carcinoma (Carcinomatosis) 06/2018 - 12/2003
2	Carcinogenesis 01/2016 - 12/2011
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 05/2012 - 09/2006
2	Hairy Cell Leukemia 05/2012 - 02/2002
2	Listeriosis (Listeria Infection) 01/2012 - 12/2002
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 02/2006 - 07/2003
2	Septic Shock (Toxic Shock Syndrome) 12/2003 - 05/2003
1	Hematologic Neoplasms (Hematological Malignancy) 01/2022

Drug/Important Bio-Agent (IBA)

14	Bevacizumab (Avastin)FDA Link 01/2022 - 09/2014
11	Hormones (Hormone)IBA 01/2022 - 11/2012
10	Cetuximab (Erbitux)FDA Link 01/2022 - 03/2011
10	Interferon Type IIBA 01/2021 - 05/2003
9	Irinotecan (Camptosar)FDA LinkGeneric 01/2022 - 03/2011
8	InterferonsIBA 10/2021 - 04/2008
7	Fluorouracil (Carac)FDA LinkGeneric 01/2022 - 12/2011
7	Everolimus FDA Link 04/2020 - 09/2007
6	Biomarkers (Surrogate Marker)IBA 01/2022 - 12/2011
6	ErbB Receptors (EGF Receptor)IBA 11/2021 - 12/2011
5	Leucovorin (Folinic Acid)FDA Link 01/2022 - 12/2011
5	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 03/2013
5	Proteins (Proteins, Gene)FDA Link 12/2016 - 12/2004
5	sodium sulfate (sodium bisulfate)FDA LinkGeneric 07/2015 - 11/2012
5	Dextrans (Dextran)FDA Link 07/2015 - 11/2012
4	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2021 - 03/2011
4	Phosphotransferases (Kinase)IBA 01/2021 - 11/2002
3	Fulvestrant (Faslodex)FDA Link 01/2022 - 01/2018
3	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2022 - 10/2006
3	Serine (L-Serine)FDA Link 10/2021 - 12/2003
3	STAT1 Transcription FactorIBA 10/2021 - 12/2011
3	CytokinesIBA 10/2021 - 01/2013
3	CyclinsIBA 01/2021 - 10/2006
3	Pharmaceutical PreparationsIBA 01/2021 - 03/2010
3	exemestane (Aromasin)FDA Link 04/2020 - 01/2019
3	Capecitabine (Xeloda)FDA Link 04/2020 - 03/2011
3	Phenobarbital (Luminal)FDA Link 04/2020 - 09/2016
3	TOR Serine-Threonine KinasesIBA 02/2019 - 10/2005
3	Biological ProductsIBA 06/2018 - 12/2004
3	AntibodiesIBA 01/2018 - 05/2012
3	16S Ribosomal RNAIBA 01/2015 - 11/2012
3	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2013 - 05/2003
3	Immunotoxins (Immunotoxin)IBA 05/2012 - 02/2002
3	Cyclin D1IBA 02/2006 - 07/2003
2	NucleotidesIBA 07/2022 - 01/2020
2	human ERBB2 proteinIBA 02/2022 - 10/2015
2	LigandsIBA 01/2022 - 12/2020
2	Angiogenesis InhibitorsIBA 12/2021 - 11/2015
2	Sunitinib (Sutent)FDA Link 12/2021 - 01/2020
2	pazopanib FDA Link 12/2021 - 01/2020
2	Formaldehyde (Formol)FDA Link 12/2021 - 03/2013
2	Vinorelbine (Navelbine)FDA LinkGeneric 11/2021 - 08/2019
2	Alanine (L-Alanine)FDA Link 10/2021 - 01/2020
2	Aromatase InhibitorsIBA 01/2021 - 01/2019
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2021 - 07/2017
2	Messenger RNA (mRNA)IBA 12/2020 - 04/2020
2	Transcription Factors (Transcription Factor)IBA 01/2018 - 02/2014
2	ChromatinIBA 01/2018 - 08/2008
2	IronIBA 12/2016 - 06/2015
2	TYK2 Kinase (Tyrosine Kinase 2)IBA 11/2015 - 01/2009
2	LipopolysaccharidesIBA 10/2014 - 05/2003
2	FlagellinIBA 05/2014 - 11/2012
2	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 02/2014 - 04/2008
2	Cadherins (E-Cadherin)IBA 07/2013 - 12/2011
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 09/2012 - 04/2008
2	Interleukin-2 (IL2)IBA 11/2010 - 02/2008
2	Proteasome Endopeptidase Complex (Proteasome)IBA 02/2006 - 07/2003
2	Sirolimus (Rapamycin)FDA Link 10/2005 - 01/2003
2	OligodeoxyribonucleotidesIBA 12/2003 - 02/2002
1	idelalisibIBA 06/2022
1	obinutuzumabIBA 06/2022
1	tirabrutinibIBA 06/2022
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 02/2022
1	venetoclaxIBA 01/2022
1	ribociclibIBA 01/2022

Therapy/Procedure

27	Therapeutics 01/2022 - 01/2003
8	Drug Therapy (Chemotherapy) 01/2022 - 09/2014
3	Combination Drug Therapy (Combination Chemotherapy) 01/2022 - 01/2019
2	Operative Surgical Procedures 01/2019 - 02/2005
2	Transplantation 01/2018 - 12/2011
2	Adjuvant Chemotherapy 01/2017 - 10/2015
2	Neoadjuvant Therapy 12/2016 - 05/2010
1	Immunotherapy 01/2022